{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T09:59:44Z","timestamp":1776247184690,"version":"3.50.1"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T00:00:00Z","timestamp":1776211200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T00:00:00Z","timestamp":1776211200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100004710","name":"Fondazione Umberto Veronesi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004710","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Familial Cancer"],"DOI":"10.1007\/s10689-026-00554-3","type":"journal-article","created":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T08:56:31Z","timestamp":1776243391000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Frequency of bilateral prophylactic and contra-lateral risk-reducing mastectomies in women with germline PALB2 variants"],"prefix":"10.1007","volume":"25","author":[{"given":"Giovanni","family":"Corso","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlo","family":"La Vecchia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Polizzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesca","family":"Magnoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuliarianna","family":"Abruzzese","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susanna","family":"Di Silvestre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Filippo","family":"Pesapane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luca","family":"Nicosia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giorgio","family":"Bogani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mattia","family":"Intra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paolo","family":"Veronesi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Viviana","family":"Galimberti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,4,15]]},"reference":[{"issue":"17","key":"554_CR1","doi-asserted-by":"publisher","first-page":"7155","DOI":"10.1073\/pnas.0811159106","volume":"106","author":"SM Sy","year":"2009","unstructured":"Sy SM, Huen MS, Chen J (2009) PALB2 is an integral component of the BRCA complex required for homologous recombination repair. Proc Natl Acad Sci U S A 106(17):7155\u20137160. https:\/\/doi.org\/10.1073\/pnas.0811159106","journal-title":"Proc Natl Acad Sci U S A"},{"key":"554_CR2","doi-asserted-by":"publisher","DOI":"10.1136\/jmg-2025-110979","author":"J Christopher","year":"2025","unstructured":"Christopher J, Edgerley K, McIldowie B, Jewell R, Kemp Z, Snape K et al (2025) Recontact and follow-up for individuals with germline pathogenic variants in hereditary breast and ovarian cancer susceptibility genes: a UK Cancer Genetics Group consensus meeting. J Med Genet. https:\/\/doi.org\/10.1136\/jmg-2025-110979. (in press)","journal-title":"J Med Genet"},{"key":"554_CR3","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.00301","volume":"10","author":"S Wu","year":"2020","unstructured":"Wu S, Zhou J, Zhang K, Chen H, Luo M, Lu Y et al (2020) Molecular mechanisms of PALB2 function and its role in breast cancer management. Front Oncol 10:301. https:\/\/doi.org\/10.3389\/fonc.2020.00301","journal-title":"Front Oncol"},{"key":"554_CR4","doi-asserted-by":"publisher","unstructured":"Breast Cancer Association Consortium et al (2021) Breast Cancer Risk Genes\u2013Association Analysis in More than 113,000 Women. N Engl J Med 384(5):428\u2013439. https:\/\/doi.org\/10.1056\/NEJMoa1913948","DOI":"10.1056\/NEJMoa1913948"},{"issue":"12","key":"554_CR5","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1016\/j.annonc.2025.09.007","volume":"36","author":"HJ Burstein","year":"2025","unstructured":"Burstein HJ, Curigliano G, Gnant M, Loibl S, Regan MM, Loi S et al (2025) Tailoring treatment to cancer risk and patient preference: the 2025 St Gallen International Breast Cancer Consensus Statement on individualizing therapy for patients with early breast cancer. Ann Oncol 36(12):1433\u20131446. https:\/\/doi.org\/10.1016\/j.annonc.2025.09.007","journal-title":"Ann Oncol"},{"issue":"5","key":"554_CR6","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1002\/jso.27817","volume":"130","author":"P Humar","year":"2024","unstructured":"Humar P, Balogun Z, Douglas N, Glenney A, Kass NM et al (2024) Factors influencing prophylactic surgical intervention in women with genetic predisposition for breast cancer. J Surg Oncol 130(5):990\u2013996. https:\/\/doi.org\/10.1002\/jso.27817","journal-title":"J Surg Oncol"},{"issue":"1","key":"554_CR7","doi-asserted-by":"publisher","DOI":"10.3390\/cancers16010103","volume":"16","author":"T Liu","year":"2023","unstructured":"Liu T, Yu J, Gao Y, Ma X, Jiang S, Gu Y et al (2023) Prophylactic interventions for hereditary breast and ovarian cancer risks and mortality in BRCA1\/2 carriers. Cancers (Basel) 16(1):103. https:\/\/doi.org\/10.3390\/cancers16010103","journal-title":"Cancers (Basel)"},{"issue":"7","key":"554_CR8","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1200\/JCO.19.01907","volume":"38","author":"X Yang","year":"2020","unstructured":"Yang X, Leslie G, Doroszuk A, Schneider S, Allen J, Decker B et al (2020) Cancer risks associated with germline PALB2 pathogenic variants: an international study of 524 families. J Clin Oncol 38(7):674\u2013685. https:\/\/doi.org\/10.1200\/JCO.19.01907","journal-title":"J Clin Oncol"},{"issue":"11","key":"554_CR9","doi-asserted-by":"publisher","first-page":"4874","DOI":"10.1177\/00031348211011056","volume":"89","author":"V Bonev","year":"2023","unstructured":"Bonev V (2023) A case report of breast implant-associated anaplastic large-cell lymphoma in a PALB2 mutation-positive woman. Am Surg 89(11):4874\u20134877. https:\/\/doi.org\/10.1177\/00031348211011056","journal-title":"Am Surg"},{"issue":"2","key":"554_CR10","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1007\/s10549-018-5045-y","volume":"174","author":"T Donenberg","year":"2019","unstructured":"Donenberg T, George S, Ali J, Bravo G, Hernandez K, Sookar N et al (2019) A clinically structured and partnered approach to genetic testing in Trinidadian women with breast cancer and their families. Breast Cancer Res Treat 174(2):469\u2013477. https:\/\/doi.org\/10.1007\/s10549-018-5045-y","journal-title":"Breast Cancer Res Treat"},{"issue":"11","key":"554_CR11","doi-asserted-by":"publisher","first-page":"8411","DOI":"10.1245\/s10434-025-17859-9","volume":"32","author":"L Kerivan","year":"2025","unstructured":"Kerivan L, Wagner J, Nye L, Balanoff C, Jeffers E, Kilgore L et al (2025) Surgical choice among women with a first breast cancer and pathogenic variants in breast cancer genes. Ann Surg Oncol 32(11):8411\u20138420. https:\/\/doi.org\/10.1245\/s10434-025-17859-9","journal-title":"Ann Surg Oncol"},{"key":"554_CR12","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-025-18343-0","author":"A Melanson","year":"2025","unstructured":"Melanson A, Mashal S, Apostolova C, Ferroum A, Basik M, Boileau JF et al (2025) Uptake of risk reducing mastectomy in older BRCA1\/2 and PALB2 carriers undergoing genetic testing after 60 years of age. Ann Surg Oncol. https:\/\/doi.org\/10.1245\/s10434-025-18343-0","journal-title":"Ann Surg Oncol"},{"issue":"11","key":"554_CR13","doi-asserted-by":"publisher","first-page":"6660","DOI":"10.1245\/s10434-022-11916-3","volume":"29","author":"SM Wong","year":"2022","unstructured":"Wong SM, Ferroum A, Apostolova C, Alhassan B, Prakash I, Basik M et al (2022) Incidence of occult breast cancer in carriers of BRCA1\/2 or other high-penetrance pathogenic variants undergoing prophylactic mastectomy: when is sentinel lymph node biopsy indicated? Ann Surg Oncol 29(11):6660\u20136668. https:\/\/doi.org\/10.1245\/s10434-022-11916-3","journal-title":"Ann Surg Oncol"},{"key":"554_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.humpath.2023.11.010","volume":"151","author":"B Boyraz","year":"2024","unstructured":"Boyraz B, Ly A (2024) Spectrum of histopathologic findings in risk-reducing bilateral prophylactic mastectomy in patients with and without BRCA mutations. Hum Pathol 151:105534. https:\/\/doi.org\/10.1016\/j.humpath.2023.11.010","journal-title":"Hum Pathol"},{"issue":"12","key":"554_CR15","doi-asserted-by":"publisher","first-page":"6990","DOI":"10.1245\/s10434-023-14141-8","volume":"30","author":"JQ Zhang","year":"2023","unstructured":"Zhang JQ, Dos Anjos CH, Sevilimedu V, Crown A, Amoroso KA, Pilewskie ML et al (2023) Association of moderate-risk breast cancer genes with contralateral prophylactic mastectomy and bilateral disease. Ann Surg Oncol 30(12):6990\u20136999. https:\/\/doi.org\/10.1245\/s10434-023-14141-8","journal-title":"Ann Surg Oncol"},{"issue":"4","key":"554_CR16","doi-asserted-by":"publisher","first-page":"e194","DOI":"10.1016\/j.clbc.2023.02.004","volume":"23","author":"MG Fencer","year":"2023","unstructured":"Fencer MG, Krupa KA, Bleich GC, Grumet S, Eladoumikdachi FG, Kumar S et al (2023) Diagnosis, management, and surveillance for patients with PALB2, CHEK2, and ATM gene mutations. Clin Breast Cancer 23(4):e194\u2013e199. https:\/\/doi.org\/10.1016\/j.clbc.2023.02.004","journal-title":"Clin Breast Cancer"},{"key":"554_CR17","doi-asserted-by":"publisher","DOI":"10.21037\/tbcr-22-33","volume":"3","author":"MK Masanam","year":"2022","unstructured":"Masanam MK, Pitcher CW, Sogunro O, Starks LK, Murray AB, Boisvert ME (2022) Risk-reducing surgery in PALB2 mutations carriers with breast cancer: a case series and literature review. Transl Breast Cancer Res 3:37. https:\/\/doi.org\/10.21037\/tbcr-22-33","journal-title":"Transl Breast Cancer Res"},{"issue":"2","key":"554_CR18","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1007\/s10549-020-05699-y","volume":"182","author":"D Cragun","year":"2020","unstructured":"Cragun D, Weidner A, Tezak A, Clouse K, Pal T (2020) Cancer risk management among female BRCA1\/2, PALB2, CHEK2, and ATM carriers. Breast Cancer Res Treat 182(2):421\u2013428. https:\/\/doi.org\/10.1007\/s10549-020-05699-y","journal-title":"Breast Cancer Res Treat"}],"container-title":["Familial Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10689-026-00554-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10689-026-00554-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10689-026-00554-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T08:56:32Z","timestamp":1776243392000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10689-026-00554-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,15]]},"references-count":18,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,6]]}},"alternative-id":["554"],"URL":"https:\/\/doi.org\/10.1007\/s10689-026-00554-3","relation":{},"ISSN":["1573-7292"],"issn-type":[{"value":"1573-7292","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,15]]},"assertion":[{"value":"4 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors do not have any conflicts of interest to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"40"}}